MedPath
NMPA Approval

Golimumab Injection

国药准字SJ20170050

October 10, 2024

S20170050

Drug Information

戈利木单抗注射液

欣普尼

注射剂

50mg(0.5ml)/支

生物制品

October 10, 2024

October 9, 2029

Company Information

Applicant Company

Einsteinweg 101, 2333 CB Leiden The Netherlands

Manufacturing Company

Cilag AG

Hochstrasse 201, Schaffhausen, 8200, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

戈利木单抗注射液 - NMPA 批准文号 | MedPath